Europe — EMA
Olimestra (Olmesartan Medoxomil)
Olmesartan Medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adults and helps reduce the risk of cardiovascular events.
Request sourcing
What is Olmesartan Medoxomil?
Olmesartan Medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adults and helps reduce the risk of cardiovascular events. GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olmesartan Medoxomil used for?
Olimestra is an angiotensin II receptor blocker that lowers blood pressure by inhibiting the renin‑renin‑angiotensin‑aldosterone system.
- Hypertension: Lowers systolic and diastolic blood pressure in patients with primary essential hypertension. - Heart failure: Improves cardiac output by ...
What are the side effects of Olmesartan Medoxomil?
Common ...
Product details
Related products

OLMESARTAN MEDOXOMIL 5 mg/1
Olmesartan medoxomil · 5 mg

OLMESARTAN MEDOXOMIL 5 mg/1
Olmesartan medoxomil · 5 mg

OLMESARTAN MEDOXOMIL 20 mg/1
Olmesartan medoxomil · 20 mg

OLMESARTAN MEDOXOMIL 20 mg/1
Olmesartan medoxomil · 20 mg